Oppenheimer Initiates Coverage on Eurand (EURX)
EURX Hot Sheet
Rating Summary:1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 5 | New: 9
Oppenheimer initiates coverage on Eurand (Nasdaq: EURX) with an Outperform. Price target $16.
To see more analyst ratings on EURX Click Here.
Eurand N.V. (Eurand), formerly known as Eurand B.V., is a specialty pharmaceutical company.
To see more analyst ratings on EURX Click Here.
Eurand N.V. (Eurand), formerly known as Eurand B.V., is a specialty pharmaceutical company.
You May Also Be Interested In
- Needham & Company Reiterates a 'Buy' on UQM Technologies (UQM); Increasing EV Adoption
- Stephens Starts RF Micro Devices (RFMD) at Overweight
- Auriga Cuts PT and Estimates on HEICO (HEI); Cautious on Decelerating FSG Growth
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
